Contracts › 75D30123C17983
75D30123C17983: Demonstrating Pan-Pathogen and Pathogen-Agnostic Genomic Surveillance of Clinical Respiratory Disease
Awarded to The Broad Institute, Inc by Centers for Disease Control and Prevention (CDC).
$4.6Mobligated
$4.6Mpotential value
31 March 2027current end date
See modifications, all subcontractors and funding in FedSift →
| Contract | 75D30123C17983 |
|---|---|
| Awardee | The Broad Institute, Inc |
| Awarding agency | Centers for Disease Control and Prevention (CDC) |
| Awarding office | CDC OFFICE OF ACQUISITION SERVICES |
| NAICS | 541714 Research and Development in Biotechnology (Except Nanobiotechnology) |
| PSC | AN11 Health R&D Services; Health Care Services; Basic Research |
| Place of performance | MA |
| Offers received | 38 |
| Period of performance | 29 September 2023 to 31 March 2027 |
| Potential end | 31 March 2027 |
| Estimated recompete solicitation | Now / imminent (estimate, ~6 months before expiry) |
Source: USASpending.gov (FPDS), public federal procurement data, as the agency reported it. Our record updated 03 October 2026. The solicitation date is an estimate from the end date, not a posted date.
Other expiring 541714 contracts · All expiring contracts · USASpending record